908 Devices Inc
908 Devices Inc (MASS) Option Chain
As of September 18, 2026, 908 Devices Inc is trading at $10.53, a -4.10% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 76.1%. IV Rank is 3%.
Read more
Tracking the MASS option chain helps you see every strike and expiry on 908 Devices Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. 908 Devices Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of MASS options activity at a glance. Use our scanner to monitor the MASS option chain in real time and filter for the MASS options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For MASS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the MASS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where MASS stock options are being actively traded and where they are not.
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis.
It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls 908 Devices Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen MASS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of MASS stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile1.59% Subdued
- Market cap (M$)435
- 52 weeks high-6.40%
- 52 weeks low109.34%
- Analyst recommendationStrong Buy
1.00 - Target price$13.12
24.60% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-09
- P/E—
- Future P/E—
- EPS (ttm)-0.94
- EPS growth next 5 years-15.07%
As of September 18, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.02 | 0 | 0 | 0.02 | 5.53 | 4.10 | 7.00 | 5.00 | -52.52 | — | 0.95 | 0.00 | 0.95 | 0 | 0 | 99.98 |
| 6.14 | 0 | 0 | 0.35 | 3.03 | 2.35 | 4.40 | 7.50 | -28.77 | — | 0.95 | 0.00 | 0.95 | 0 | 0 | 93.86 |
| 43.69 | 503 | 0 | 0.47 | 0.53 | 0.10 | 1.90 | 10.00 | -5.03 | 0.40 | 0.65 | 0.00 | 0.53 | 1 | 21 | 56.31 |
| 81.99 | 14 | 10 | 0.65 | 0.00 | — | 0.65 | 12.50 | +18.71 | 0.95 | 3.80 | 1.97 | 0.40 | 0 | 0 | 18.01 |
| 96.35 | 5 | 0 | 0.25 | 0.00 | — | 0.25 | 15.00 | +42.45 | 3.10 | 6.00 | 4.47 | 0.08 | 0 | 0 | 3.65 |
As of September 18, 2026
Scan the full option chain in one place
Browse the full MASS option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→